BiotechTube
Home/Nanoligent/Dr. A. Villaverde
DA

Dr. A. Villaverde

Co-Founder

Nanoligent

Therapeutic Areas

Oncology

Nanoligent Pipeline

DrugIndicationPhase
CXCR4-Targeted TherapyOncology (Tumor Growth & Metastasis)Preclinical

Leadership Team at Nanoligent

DE
Dr. E. Vázquez
Co-Founder
DR
Dr. R. Mangues
Co-Founder
DM
Dr. M. Rodríguez
Co-Founder & Entrepreneur
View full Nanoligent profile